*Human Total Factor XII ELISA KitIHUFXIIKTT
Select this product for Molecular Innovations name, Human Coagulation Factor XII Total Antigen ELISA Kit and product number, HFXIIKT-TOT.
Human Total Factor XII ELISA Kit from Innovative Research is intended for the quantitative determination of total FactorÂ XII antigen in human plasma and serum. Strip well format. Reagents for up to 96 tests.
Human Factor XII will bind to the affinity purified capture antibody coated on the microtiter plate. Factor XII and XIIa will react with the antibody on the plate. After appropriate washing steps, anti?human Factor XII primary antibody binds to the captured protein. Excess primary antibody is washed away and bound antibody, which is proportional to the total Factor XII present in the samples, is reacted with the secondary antibody. Following an additional washing step, TMB substrate is used for color development at 450nm.
- Detection Target: Total Factor XII
- Reactivity: Human
- Cross-Reactivity: At recommended dilution no significant cross-reaction occurs with rat, Porcine, dog, rabbit or sheep.
- Range: 0.5?100Â ng/ml
- Sensitivity: 0.098 ng/ml
- Storage Conditions: 2-8Â°C
Please note, pooled normal plasma from mouse resulted in significant background color development. At Innovative Research, we provide reliable, consistent products that deliver reliable, consistent results.
This material is sold for in-vitro use only for manufacturing and research. This material is not suitable for human or animal use. While we make every effort to ensure the safety of our products, we recommend handling any biological materials with standard precautions as if capable of spreading infectious disease. The statements herin are offered for informational purposes only to be used solely for your consideration, investigation, and verification.
Please be aware the image pictured is for illustrative purposes only, and your product packaging and appearance may vary.
Get in touch with our team! Please include any relevant information (product name, etc)